טוען...

(+)-Naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats

Previous work demonstrated that both the opioid antagonist (−)-naloxone and the nonopioid (+)-naloxone inhibit toll-like receptor 4 (TLR4) signaling and reverse neuropathic pain expressed shortly after chronic constriction injury. The present studies reveal that the TLR4 contributes to neuropathic p...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Lewis, Susannah S., Loram, Lisa C., Hutchinson, Mark R., Li, Chien-Ming, Zhang, Yingning, Maier, Steven F., Huang, Yong, Rice, Kenner C., Watkins, Linda R.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2012
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3348259/
https://ncbi.nlm.nih.gov/pubmed/22520687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpain.2012.02.005
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!